A genetic “smart pill” can raise awareness, focus, clarity, mental acuity and creativity, supplying a lifelong cognitive boost which can elevate a person’s economic value to employers and enhance their quality and life.

The long-range market potential for genetic cognitive enhancement is estimated at $1 trillion.

A robust intellectual property portfolio provides the company with early control of this emerging industry.